Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
for   save search
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 20:00) - globenewswire.com
POAI | $1.34 3.88% 3.73% 24K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
presentation for meeting
Lam Research Corporation Reports Financial Results for the Quarter Ended March 31, 2024
Published: 2024-04-24 (Crawled : 20:00) - prnewswire.com
LRCX | $884.89 -0.29% -1.54% 1.6M twitter stocktwits trandingview |
Electronic Technology
 | Email alert Add to watchlist
corporation research for financial results
Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 19:00) - biospace.com/
PGEN | $1.42 1.43% 1.41% 570K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 2.14% C: 1.43%
prgn-2012 respiratory asco treatment immunotherapy for meeting study
Kingswood U.S. Named To USA Today's List of Best Financial Advisory Firms for Second Straight Year
Published: 2024-04-24 (Crawled : 19:00) - prnewswire.com
SMXT | $8.02 -12.35% -14.23% 210K twitter stocktwits trandingview |
| Email alert Add to watchlist
year for best financial usa
Results of Novocure’s METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024
Published: 2024-04-24 (Crawled : 19:00) - biospace.com/
NVCR | $12.34 2.36% 2.39% 1.3M twitter stocktwits trandingview |
Health Technology
 | | O: 0.33% H: 2.48% C: 2.07%
lung asco cancer cell for trial results
SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 17:00) - globenewswire.com
SWTX | $43.38 -1.41% -1.45% 500K twitter stocktwits trandingview |
Health Technology
 | | O: -0.05% H: 2.16% C: -1.36%
presentation for meeting therapeutics
Profire Energy Sets First Quarter 2024 Earnings Call for Thursday, May 9, 2024, at 8:30 a.m. ET
Published: 2024-04-24 (Crawled : 17:00) - globenewswire.com
PFIE 4 | $1.85 -1.07% 0.0% 72K twitter stocktwits trandingview |
Producer Manufacturing
 | | O: 0.0% H: 2.67% C: -1.07%
first energy for
Investing in People and Technology: First Advantage Receives Two Silver Stevie® Awards for Sales & Customer Service 
Published: 2024-04-24 (Crawled : 17:00) - fadv.com
STER | $15.33 0.33% 0.42% 320K twitter stocktwits trandingview |
| | O: -0.07% H: 1.38% C: 0.39%
stevie sales first advantage awards for
What's New in The Palm Beaches for Spring 2024
Published: 2024-04-24 (Crawled : 16:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
 | Email alert Add to watchlist
spring for
First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 twitter stocktwits trandingview |
Health Technology
 | | O: 0.8% H: 0.0% C: -1.05%
PRGO | $31.23 2.43% 0.0% 960K twitter stocktwits trandingview |
Health Technology
 | | O: 0.1% H: 0.0% C: 0.0%
JNJ | News | $148.53 -0.69% 0.18% 7.5M twitter stocktwits trandingview |
Health Technology
 | | O: -1.02% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% 0.07% 4.2M twitter stocktwits trandingview |
Health Technology
 | | O: -0.82% H: 0.37% C: 0.17%
XOMA | $25.64 -1.73% -3.9% 8.2K twitter stocktwits trandingview |
Health Technology
 | | O: 0.19% H: 0.0% C: -1.91%
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
 | | O: 0.82% H: 0.0% C: 0.0%
rare first opioid approval for
MagiQ Technologies Taps Sandia Labs for Extreme Seismic Sensor Tests; Results Far Exceed High Temperature Benchmarks for Geothermal Applications
Published: 2024-04-24 (Crawled : 15:00) - prnewswire.com
HON | News 4 | $194.79 -0.7% -0.74% 2.3M twitter stocktwits trandingview |
Producer Manufacturing
 | | O: -1.32% H: 0.0% C: 0.0%
sensor for results
Verizon readies for 2024 wildfire season
Published: 2024-04-24 (Crawled : 15:00) - globenewswire.com
VZ | News | $39.49 -0.53% 0.03% 12M twitter stocktwits trandingview |
Communications
 | | O: -0.5% H: 0.41% C: -0.03%
for
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior ExchangeStrategic Audit Completion Set to Enhance BioStem Technologies' Market Position and Shareholder Value
Published: 2024-04-24 (Crawled : 15:00) - biospace.com/
BSEM | $9.355 1.24% -38.71% 24K twitter stocktwits trandingview |
n/a
 | | O: 0.0% H: 1.73% C: 1.3%
for set market
BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
BTAI | News | $2.71 -8.75% -10.0% 870K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 0.67% C: -8.75%
bxcl701 keytruda presentation asco pancreatic for meeting trial therapeutics
Juniata Valley Financial Corp. Announces Results for the Quarter Ended March 31, 2024
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
JUVF 4 | $11.52 -0.26% 21.46% 0 twitter stocktwits trandingview |
Finance and Insurance
 | Email alert Add to watchlist
for financial results
Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
Published: 2024-04-24 (Crawled : 14:00) - biospace.com/
SNPX | $4.56 -0.22% 0.65% 14K twitter stocktwits trandingview |
Professional, Scientific, and T...
 | | O: 0.22% H: 2.4% C: -0.44%
nasdaq for
GoodRx Announces Date for 2024 Investor Day
Published: 2024-04-24 (Crawled : 14:00) - biospace.com/
GDRX 4 | $6.96 -0.14% -0.14% 800K twitter stocktwits trandingview |
Technology Services
 | | O: 5.64% H: 0.0% C: 0.0%
day for
IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study
Published: 2024-04-24 (Crawled : 14:00) - prnewswire.com
IDYA | News | $39.85 2.13% 2.08% 1.4M twitter stocktwits trandingview |
Health Technology
 | | O: 0.28% H: 3.02% C: 1.84%
melanoma presentation asco for study
ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
ALXO M | $16.22 4.65% 4.56% 440K twitter stocktwits trandingview |
Commercial Services
 | | O: 0.58% H: 4.23% C: 4.04%
presentation asco for meeting
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
MRUS | $41.97 2.82% 2.72% 740K twitter stocktwits trandingview |
Health Technology
 | | O: 0.44% H: 2.49% C: 2.37%
presentation asco for meeting
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M twitter stocktwits trandingview |
Consumer Services
BOF | $2.08 77.78% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.54 12.27% 40.62% 3.7M twitter stocktwits trandingview |

LICN | $0.999 78.39% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.4 70.0% 39.58% 70M twitter stocktwits trandingview |
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M twitter stocktwits trandingview |
Technology Services
WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services
AIH | $0.458 14.5% 30.92% 91K twitter stocktwits trandingview |
Health Services
WHLM | $6.25 35.87% 28.46% 700K twitter stocktwits trandingview |
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M twitter stocktwits trandingview |
Information
Your saved searches
Save your searches and get alerts when important news are released.